TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Description

TCV vaccines market is estimated to be valued at USD 412.8 Mn in 2024 and is expected to reach USD 935.9 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	412.8 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	12.40%	2031 Value Projection:	935.9 Mn

Figure. TCV Vaccines Market Share (%), By Region, 2024

The TCV vaccines market has been witnessing steady growth over the past few years due to increasing incidence of diseases and infections. TCV vaccines target tetanus, diphtheria, and pertussis/whooping cough which are highly infectious bacterial respiratory diseases. Pertussis is especially dangerous for infants and young children which has been a key factor driving vaccination programs globally. While tetanus and diphtheria vaccination rates are high worldwide, pertussis continues to spread in schools and communities necessitating regular booster doses. Growing awareness about benefits of immunization and government efforts to strengthen routine immunization programs in developing countries have boosted market revenues. Recent new product approvals and large clinical trials evaluating expansion of indication have further widened growth opportunities in this market.

Market Dynamics:

TCV vaccines market is expected to witness robust growth going forward on account of rising demand from developing regions and increasing coverage of vaccination programs worldwide. The key drivers fueling the market include growing awareness among parents, expanding recommendation by international health organizations to protect vulnerable population groups, and government subsidies and funding in low and middle income nations. However, high costs associated with R&D, manufacturing, and distribution of combination vaccines pose a major challenge to adoption rates. In addition, ongoing vaccine hesitancy due to misinformation and religious beliefs inhibits market potential in some countries.

Key Features of the Study:

This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global TCV vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GSK plc., Sanofi, Bharat Biotech, BioFarma, Zydus Group, Emergent BioSolutions Inc., Bavarian Nordic Inc., Crucell Switzerland LTD., PaxVax, Inc., and BIO-MED

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market

Market Segmentation

By Vaccine Brand Insights (Revenue, USD Mn, 2019 - 2031)
- Ty21a (Vivotif)
- ViCPS (Typhim Vi)
- Vi-TT (Peda-typhTM)
- Typbar TCV
By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Public
- UNICEF
- Tender (Govt.)
- Private
Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GSK plc.
- Sanofi
- Bharat Biotech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED

Product Code: CMI4936

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- TCV Vaccines Market, By Vaccine Brand
- TCV Vaccines Market, By Distribution Channel
- TCV Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends
Epidemiology

4. Global TCV Vaccines Market, By Vaccine Brand, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Ty21a (Vivotif)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
ViCPS (Typhim Vi)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vi-TT (Peda-typhTM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Typbar TCV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global TCV Vaccines Market, By Distribution Channel, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
UNICEF
Tender (Govt.)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global TCV Vaccines Market, By Region, 2019 - 2031, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioFarma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zydus Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bavarian Nordic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Crucell Switzerland LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PaxVax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BIO-MED
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

8. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. References and Research Methodology

References
Research Methodology
About us